Fusion Pharmaceuticals Inc (FUSN)
21.42
-0.02
(-0.12%)
USD |
NASDAQ |
May 06, 16:00
21.42
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 2.006M |
June 30, 2023 | 0.034M |
March 31, 2023 | 0.028M |
December 31, 2022 | 0.14M |
September 30, 2022 | 0.166M |
Date | Value |
---|---|
June 30, 2022 | 0.57M |
March 31, 2022 | 0.585M |
December 31, 2021 | 0.594M |
September 30, 2021 | 0.325M |
June 30, 2021 | 0.521M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.028M
Minimum
Mar 2023
2.006M
Maximum
Sep 2023
0.4969M
Average
0.423M
Median
Revenue (Quarterly) Benchmarks
AstraZeneca PLC | 12.68B |
Landos Biopharma Inc | -- |
Perspective Therapeutics Inc | -5.239M |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 45.10M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -28.18M |
Total Expenses (Quarterly) | 28.28M |
EPS Diluted (Quarterly) | -0.39 |
Enterprise Value | 1.618B |
Earnings Yield | -6.86% |
Normalized Earnings Yield | -7.608 |